Monograph Details
|
|
Urogenital System
> Urinary tract disorders
|
|
CYSTOSPAZ |
| Manufacturer |
|
Amerifit Nutrition, Inc. |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Antispasmodic. |
| Generic Name |
|
Hyoscyamine 0.15mg; tabs. |
| Indications |
|
Lower urinary tract spasm. |
| Children |
|
Reduce dose. |
| Adults |
|
1–2 tabs 4 times daily. |
| Contraindications |
|
Glaucoma. Unstable cardiovascular status in acute hemorrhage. GI or urinary tract obstruction. Paralytic ileus, intestinal atony of elderly or debilitated patients. Toxic megacolon. Severe ulcerative colitis. Myasthenia gravis. |
| Precautions |
|
High environmental temperatures. Autonomic neuropathy. Hyperthyroidism. Coronary heart disease. CHF. Arrhythmias. Hypertension. Tachycardia. Hiatal hernia associated with reflux esophagitis. Pregnancy (Cat.C). Nursing mothers. |
| Interactions |
|
Antacids may inhibit absorption. Additive anticholinergic effects with other anticholinergics, amantadine, haloperidol, phenothiazines, MAOIs, tricyclics, antihistamines. |
| Adverse Reactions |
|
Anticholinergic effects, headache, drowsiness, urticaria. |
| How Supplied |
|
Tabs—100 |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
